Browse by author
Lookup NU author(s): Professor Ann DalyORCiD,
Dr Santosh Gupta
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Drug metabolism may be perturbed by genetically determined differences in the metabolic activity of cytochrome P450 enzymes. The authors encountered extensive bleeding in a patient receiving warfarin for anticoagulation after the introduction of celecoxib, an anti-inflammatory drug. As the CYP2C9 enzyme metabolises these drugs, it was determined whether variant alleles were responsible for altering warfarin handling. Genetic analysis established that the patient was a compound heterozygote with CYP2C9*2 and *3 variant alleles, which exhibit lower drug metabolising capacity and enhance susceptibility to drug toxicity.
Author(s): Malhi H, Atac B, Daly AK, Gupta S
Publication type: Article
Publication status: Published
Journal: Postgraduate Medical Journal
Print publication date: 01/02/2004
ISSN (print): 0032-5473
ISSN (electronic): 1469-0756
Publisher: BMJ Group
PubMed id: 14970301
Altmetrics provided by Altmetric